These pathways were disease-relevant because the levels of TGF-β and Ang II were increased and positively correlated with Smad2/3 in tissues from patients with idiopathic pulmonary fibrosis or scleroderma-associated interstitial lung disease. The gene discussed is SMAD2; the disease is scleroderma.